Janssen’s exclusive 8.7 trillion immune disease treatment market opens… Selt, Samba, and Dong-A’s 3rd wave warfare
Enter 2021.03.27 06:00 Preparing to launch generic drugs in time for patent expiration in 2023Celltrion leads to Phase 3 clinical trials… “Completed next year”Samsung Bioepis and …
